Relevant bibliographies by topics / Seborrheic Dermatitis

Academic literature on the topic 'Seborrheic Dermatitis'

Author: Grafiati
Published: 4 June 2021
Last updated: 4 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Seborrheic Dermatitis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Seborrheic Dermatitis"

1

Одинцова, Инна, and Анатолий Дюдюн. "The composition of microorganisms in the skin lesions focus in patients with seborrheic dermatitis." Dermatovenerology. Cosmetology. Sexopathology, no. 3-4 (November 28, 2019): 38–41. http://dx.doi.org/10.37321/dermatology.2019.3-4-05.

Full text
Abstract:
The purpose of the work is monitoring the microbial landscape of the skin of patients with seborrheic dermatitis. Materials and research methods. We observed 67 patients with seborrheic dermatitis aged 18 to 57 years. The average age of the patients was 27.5 years. All patients with seborrheic dermatitis were examined using the following methods: skin examination; microscopic, bacteriological methods; a general and biochemical blood test; a general urinalysis; consideration of the patient's subjective sensations. Results and its discussion. Among patients with seborrheic dermatitis, fatty seborrhea was found in 39 (58 %), a mixed form of seborrheic dermatitis was found in 20 (30 %) patients. While bacteriological and microscopic examination of the sampling material from the affected areas of the skin of patients with seborrheic dermatitis is carried out, it is noteworthy to consider that in 59 (88.1%) patients Malassezia spp. is detected, which indicates a certain its value in the occurrence and course of the pathological condition. Among other microorganisms the examinations revealed: St. capitis - at 54 (80.1 %), St. epidermidis - at 36 (53.7 %), Micrococcus spp. - at 20 (29.9 %), Acinetobacter spp. - at 10 (14.9 %). With a lesser degree of contamination, St. aureus, St. capitis, St. hominis, St. cohnii, St. xylosus have been found. Conclusions. It is necessary to consider the presence of fungi Malassezia spp. in association with pathogenic and conditionally pathogenic microorganisms that support the inflammatory process and affect the development and course of the disease while planning the treatment of patients with seborrheic dermatitis.
APA, Harvard, Vancouver, ISO, and other styles
2

Adhikary, Sahadev Kumar, Md Eakub Ali, Md Jamal Uddin, Shireen Akter, Masood Mohammad Abdul Aziz, Farhana Ferdaus, and Ratan Lal Dutta Banik. "A Study on Efficacy of Oral Itraconazole in the Treatment of Seborrheic Dermatitis." Faridpur Medical College Journal 16, no. 1 (October 3, 2021): 21–24. http://dx.doi.org/10.3329/fmcj.v16i1.55732.

Full text
Abstract:
Seborrheic dermatitis is a common chronic disease. Malassezia yeasts have been implicated in the pathogenesis of this disease. Antifungal agents are known to be effective in the treatment of Malassezia yeast infections. This study was done to evaluate the efficacy of itraconazole in the treatment of seborrheic dermatitis. Sixty patients with Seborrheic dermatitis were evaluated in an open non-comparative study. Patients were treated with itraconazole capsule 100 mg twice a day for a week; then after a 3-week interval 100 mg capsule was given twice a day for 2 days of following months for two consecutive months. Four clinical parameters (Itching, burning erythema, scaling, and seborrhea) were assessed using a 0 to 3-point (0= absent, 1 = mild, 2 = moderate, 3 = severe) score. Mycological evaluation determined the presence of Malassezia spores in the scales using a direct smear. At the end of the initial treatment significant improvement was reported in four clinical parameters: Itching, burning erythema, scaling, and seborrhea. Maintenance therapy led to further improvement slightly. Burning sensation mildly improved during the treatment. The quantity of Malassezia spores present in the direct smear decreased throughout the treatment period. Blood test abnormalities were not found during the treatment. So initial treatment with itraconazole is beneficial in patients with seborrheic dermatitis. Faridpur Med. Coll. J. 2021;16(1):21-24
APA, Harvard, Vancouver, ISO, and other styles
3

Abdulla, Farah Rukhsana, and Robert T. Brodell. "Seborrheic dermatitis." Postgraduate Medicine 117, no. 3 (March 2005): 43–44. http://dx.doi.org/10.3810/pgm.2005.03.1602.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cotterill, Paul C. "Seborrheic Dermatitis." International Society of Hair Restoration Surgery 7, no. 6 (November 1997): 13.2–13. http://dx.doi.org/10.33589/7.6.13b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gupta, AK, and R. Bluhm. "Seborrheic dermatitis." Journal of the European Academy of Dermatology and Venereology 18, no. 1 (January 2004): 13–26. http://dx.doi.org/10.1111/j.1468-3083.2004.00693.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sa�ar, Tuncer. "Seborrheic Dermatitis." Journal of Clinical and Analytical Medicine 2, no. 2 (May 1, 2011): 57–60. http://dx.doi.org/10.4328/jcam.116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Naldi, Luigi, and Alfredo Rebora. "Seborrheic Dermatitis." New England Journal of Medicine 360, no. 4 (January 22, 2009): 387–96. http://dx.doi.org/10.1056/nejmcp0806464.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schmidt, Jennifer A. "Seborrheic Dermatitis." Journal of the Dermatology Nurses' Association 3, no. 5 (September 2011): 294–99. http://dx.doi.org/10.1097/jdn.0b013e31822f48eb.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gupta, Aditya K., Robyn Bluhm, Elizabeth A. Cooper, Richard C. Summerbell, and Roma Batra. "Seborrheic dermatitis." Dermatologic Clinics 21, no. 3 (July 2003): 401–12. http://dx.doi.org/10.1016/s0733-8635(03)00028-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schmidt, Jennifer A. "Seborrheic Dermatitis." Nurse Practitioner 36, no. 8 (August 2011): 32–37. http://dx.doi.org/10.1097/01.npr.0000399717.56736.1e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Seborrheic Dermatitis"

1

Casas, Fernando Constantino. "A seborrheic dermatitis in pygmy goats." Thesis, University of Cambridge, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.385334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Moraes, Andrea Pinheiro de. "AvaliaÃÃo terapÃutica do pimecrolimo creme 1% no tratamento da dermatite seborrÃica da face de pacientes com HIV- Positivos." Universidade Federal do CearÃ, 2006. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=216.

Full text
Abstract:
A dermatite seborrÃica (DS) Ã uma das doenÃas mais comum entre os pacientes portadores do vÃrus HIV afetando entre 40 a 80% dos pacientes com AIDS e 20 a 40% dos pacientes soropositivos para o vÃrus HIV. Com o intuito de avaliar a eficÃcia terapÃutica e seguranÃa do pimecrolimo creme 1% na DS de face de pacientes HIV-positivos, foi realizado estudo fase II. Inicialmente quatro pacientes (Grupo A) portadores de DS leve a severa foram tratados com o pimecrolimo duas vezes por dia por 7 dias e o segundo grupo (Grupo B) vinte e um pacientes, foram tratados com pimecrolimo duas vezes por dia por 14 dias. Em seguida o tratamento era descontinuado e os pacientes foram acompanhados por mais 5 semanas. A avaliaÃÃo das lesÃes foi realizada no dia inicial, 7Â, 14Â, 21Â, 35Â e 49Â dia utilizando-se uma escala com pontuaÃÃo de zero a quatro para cada parÃmetro avaliado (eritema, descamaÃÃo, ardor, prurido, infiltraÃÃo/papulaÃÃo, escoriaÃÃo, liquenificaÃÃo), e tambÃm por meio de fotografia digital. Obteve-se importante melhora em todos os parÃmetros clÃnicos avaliados no 7Â dia; no 14Â dia 90% dos pacientes apresentavam-se livres de sinais. O eritema e a descamaÃÃo apresentaram recidiva em aproximadamente 50% dos pacientes no 35Â dia do estudo, mas o quadro clÃnico era menos intenso que o quadro clÃnico inicial. Todos os pacientes responderam a terapÃutica independente do seu âstatusâ imunolÃgico. O pimecrolimo creme 1% representa uma nova, atrativa e eficaz, opÃÃo terapÃutica para o tratamento da DS de face em pacientes HIV-positivos.
Seborrheic dermatitis (SD) is a one of the most common dermatosis in HIV-positive patients affecting between 40 to 80% of AIDS patients and 20 to 40% of HIV-positive patients. To investigate efficacy and safety of pimecrolimus cream 1% in HIV-positive patients with facial SD a phase II study was done. First of all 4 HIV-infected patients (Group A) with mild/severe SD were treated twice-daily with pimecrolimus cream 1% for 7 days and after this 21 HIV-infected patients (Group B) with mild/severe SD were treated twice-daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement (erythema, scaling, burning, pruritus, infiltration/papulation, excoriation and lichenification) at baseline, Days 7, 14, 21, 35 and 49 was assessed using a 4-point clinical score and digital photographs. Marked improvement was seen in clinical parameters at Day 7, with >= 90% patients clear of symptoms at Day 14. Erythema and scaling relapsed at Day 35 in approximately 50% of patients, but all symptoms were milder than at baseline. All patients responded to therapy, despite their immunologic status. Pimecrolimus cream represents a new, attractive and effective therapeutic option for facial SD in HIV-patients.
APA, Harvard, Vancouver, ISO, and other styles
3

Schechtman, Regina Casz. "Seborrhoeic dermatitis and Malassezia species : an investigation in HIV positive patients." Thesis, King's College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jiun-WenGuo and 郭俊文. "The effect of human sebum on skin barrier and its role in the pathogenesis of seborrheic dermatitis." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/07156302507137933006.

Full text
Abstract:
博士
國立成功大學
臨床藥學與藥物科技研究所
102
Seborrheic dermatitis (SD) is a common, recurrent, chronic inflammatory skin disorder. It generally arises in areas with high density of sebaceous glands. Human sebum is a complex mixture of lipids, which is secreted by mammalian sebaceous glands associated with hair follicles, and forms a fluid film over the skin surface. The functions of sebum have been known to soften the skin, to regulate the water content of the epidermis, to inhibit the growth of gram-positive bacteria and to prevent an invasion of external organisms. It was hypothesized that the Malassezia yeasts consumed the saturated fatty acids released from the triglycerides, and left behind the unsaturated fatty acids which cause inflammation and irritation. However, up to the present, there is only very limited information about the effect of sebum on skin barrier and its role in the pathogenesis of SD. Two studies were designed to clarify the sebum effect on skin barrier and its role in pathogenesis in SD. In the first study, using a hairless mouse model, we clearly demonstrated the human sebum imparts detrimental effects on the skin permeability barrier both functionally and morphologically. The underlying mechanisms for sebum-induced barrier disruption are related directly to the interaction of sebum with the intracellular lipid lamellae of the stratum corneum (SC), thereby leading to increase the fluidity of SC intracellular lipids as demonstrated by ATR-FTIR spectroscopic measurement. Direct observation of the SC lipids by ruthenium tetroxide staining under electron microscope further confirm that intercellular lipid lamellae disorganization was the earliest morphological event following sebum application. The disruption of the skin barrier elicit an epidermal inflammatory cascade with the release of IL-1α, TNF-α, and IL-6 from the keratinocytes and later inflammatory cells infiltration in the upper epidermis. Although acute increase of these cytokines is crucial for skin barrier repair, in chronic barrier disruption, these cytokines cascade could have a harmful effect leading to cutaneous chronic inflammation. Supported by the epidermal TSLP staining and serum IgE data, and also in agreement with previous reports, we may conclude that sebum-induced dermatitis resembles irritant contact dermatitis rather than allergic dermatitis. In the second study, we reported the first human study to demonstrate elevated levels of oleic acid in both the SD sebum and in the control sebum collected 72 hr versus 24 hr post hair washing. Moreover, chronic applications of SD sebum and modified control sebum with similar oleic acid content onto mouse skin resulted in a higher TEWL value than application of control sebum. These results indicated possible involvement of C18 unsaturated fatty acid, and possibly others, in the pathogenesis of SD. In summary, results from both studies in concert identified possible relationships between sebum, irritant contact dermatitis, and SD. These findings may have therapeutic implications for the treatment of SD.
APA, Harvard, Vancouver, ISO, and other styles
5

Kent, Keri. "The effectiveness of an oral homoeopathic preparation of selenium sulphide 12X in the management of dandruff (seborrheic dermatitis of the scalp)." Thesis, 2005. http://hdl.handle.net/10321/60.

Full text
Abstract:
Thesis (M.Tech.: Homoeopathy)-Dept. of Homoeopathy, Durban Institute of Technology, 2005 xxiii, 120 leaves ; 30 cm
This double-blind, placebo controlled study evaluated the effectiveness of Selenium sulphide 12X in the management of dandruff, as measured by a Visual Analogue Scale.
APA, Harvard, Vancouver, ISO, and other styles
6

Zondi, Silindelo Minenhle. "The efficacy of a topical application comprising Calendula officinalis Ø and Olea europaea in the management of seborrheic dermatitis of the scalp (dandruff)." Thesis, 2017. http://hdl.handle.net/10321/2899.

Full text
Abstract:
Submitted in partial compliance with the requirements of the Master’s Degree in Technology: Homoeopathy, Durban University of Technology, Durban, South Africa, 2017.
Background Seborrheic dermatitis (SD) also known as pityriasis capitis is a common skin condition that affects mainly the scalp, causing scaly patches, red skin and stubborn dandruff (Preedy 2012). It has been reported that dandruff occurs in at least 50% of the world’s adult population and approximately 15% to 20% of the world’s total population (Mia 2016). Recent studies suggest that a scalp specific yeast called Malasseiza globosa appears to be responsible for SD (Zhang, Ran, Xie and Zhang 2013). Seborrheic dermatitis does not affect overall health but it can be uncomfortable and may cause embarrassment and low self-esteem (Del Rosso 2011; Preedy 2012). Anecdotal evidence at Ukuba Nesibindi Homoeopathic Community Clinic (UNHCC) indicated that patients with SD responded positively to Calendula officinalis Ø in combination with Olea europaea (olive oil). Notwithstanding this, there is a dearth of clinical data available to validate the aforesaid patient’s positive response. Hence this study aims to provide clinical evidence to prove or disprove patient’s response to Calendula officinalis Ø in combination with Olea europaea (olive oil). Objective The aim of this double blind randomized controlled study was to determine the efficacy of a topical application comprising Calendula officinalis Ø with Olea europaea in the management of SD of the scalp (dandruff). Material and methods The sample was selected by means of non-probability convenience sampling and consisted of 64 consenting participants between the ages of 18 to 50 years who had read the information letter and met the inclusion criteria. Participants were evenly distributed between the treatment and control groups according to the randomization list (32 participants in each group). The treatment group received Calendula officinalis Ø with Olea europaea and the control group received Olea europaea only. Three participants withdrew from the study resulting in only 61 completing the study, 30 from the control group and 31 from the treatment group. The study was conducted at the Durban University of Technology Homoeopathic Day Clinic (DUTHDC) under the supervision of a qualified and registered homoeopathic clinician. The duration of the study was six weeks with three consultations in total. Consultations took place on day 1, day 22 and day 43. At each consultation the participants were assessed by three individuals – the participant themselves, the researcher, and an independent party (the homoeopathic clinician on duty that day). The assessment tools included the Visual Analogue Scale (VAS) for the researcher and clinician consisting of the following categories: irritation, flaking, greasiness, percentage of the scalp involved and overall impression; and the Patient Perception Questionnaire (PPQ) for the patient consisting of the following categories: irritation, flaking, greasiness, itching and overall impression. This was accompanied by a detailed case history and physical examination performed by the researcher. Results Both the control and treatment groups displayed overall improvement in terms of Patient Perception Questionnaire and Visual Analogue Scale which means that a combination of Olea europeae with Calendula officinalis Ø (treatment group) and Olea europeae only (control group) were effective in the management of SD. There was no statistically significant difference between the effect of a combination of Olea europaea with Calendula officinalis Ø and Olea europaea only. In terms of the VAS and PPQ categories, there was a statistical significance between the groups, with the exception of irritation. Significant differences found were as follows: Flaking (clinician and patient rated p = 0.019) on visit 3 for the control group. Greasiness (clinician and patient rated p = 0.027) on visit 3 for the control group. Greasiness (researcher and patient rated p = 0.012) on visit 2 for the treatment group. Percentage of the scalp involved (researcher and clinician rated p = 0.013) on visit 2 for the treatment group. Overall impression (researcher and patient rated p = 0.026) on visit 2 for the control group. Overall impression (researcher and clinician rated p = 0.026) on visit 3 for the treatment group. Conclusion Both the combination of Olea europaea with Calendula officinalis Ø and Olea europaea only improve SD. Therefore, a topical application comprising Calendula officinalis Ø and Olea europaea is effective in the management of SD of the scalp (dandruff) and therefore permits further investigation.
M
APA, Harvard, Vancouver, ISO, and other styles
7

Alkhawaja, Mariam Jamal. "A study of Th17 axis cytokines in a mouse model of cutaneous autoimmunity and of the association of the Human T-cell Leukemia Virus Type I and mycosis fungoides." Thesis, 2014. http://hdl.handle.net/1993/23252.

Full text
Abstract:
Psoriasiform diseases are a group of cutaneous disorders that are characterized by impaired keratinocyte maturation leading to epidermal hyperplasia and thickening of skin. This group of disorders includes psoriasis, seborrheic dermatitis (SD) and mycosis fungoides (MF). Psoriasis has been recently shown to be mediated by the pro-inflammatory T helper cell subset, namely Th17 cells, whereas the pathogenesis of SD and MF are still poorly understood. SD is characterized by inflamed skin that primarily manifests on areas populated with sebaceous glands. Interestingly, SD is very common amongst immunosuppressed patients such as those with HIV-AIDS, suggesting the importance of an immune response in the development of SD. Because SD shares common clinical and histopathological features with psoriasis, a disease in which Th17 axis cytokines is known to be involved, and given that Th17 cells and their related cytokines have been implicated in the pathogenesis of a wide range of autoimmune and inflammatory disorders, it is possible that Th17 axis cytokines play a role in the pathogenesis of SD. We explored the involvement of Th17 axis cytokines in a D2C mouse model of psoriasiform disease that shows a high degree homology to the clinicopathological characteristics of human seborrheic dermatitis. IL-6 and IL-23, which are important for the differentiation of Th17 cells, and IL-17 and IL-22, which are the Th17 effector molecules, were measured at both protein and mRNA levels in sera and lesional skin from D2C mice. An immunohistochemical analysis was also performed to detect the presence of IL-17 in D2C lesional skin relative to normal skin from DBA/2 controls. Our data demonstrated significantly elevated levels of IL-6, IL-17 and IL-22 in sera from diseased D2C mice compared to controls and/or convalescent mice. There were no significant differences in IL-23 protein levels in sera from D2C mice compared to those from wild type mice or convalescent D2C mice. RT-PCR revealed a significant increase in IL-23 and IL-17 gene expression in D2C lesional skin relative to normal skin. Gene expression levels of IL-22, but not IL-6, were statistically significant elevated in D2C skin lesions compared to controls, by real time PCR. Our IHC study of IL-17 expression showed an abundance of positively stained mononuclear cells in D2C lesional skin relative to DBA/2 normal skin. Altogether, our data demonstrate that Th17 axis cytokines are elevated locally at mRNA levels for IL-23, IL-17, and IL-22 and systematically at protein levels for IL-6, IL-17, and IL-22. This data lay the foundation for further studies investigating a role for Th17 axis cytokines in the cutaneous inflammatory disease seen in our mouse model of SD and, ultimately, in the development of human SD. Mycosis fungoides (MF) is the most common type of cutaneous T cell lymphoma (CTCL). The etiology of MF is unknown, but there is substantial evidence suggesting a potential role for a yet unidentified infectious agent in the pathogenesis of MF. Many studies have claimed that there is an association between MF and the Human T cell Lymphotorpic Virus Type 1 (HTLV-I); however, the involvement of this virus in the etiology of MF is a controversial topic. In our study, we used nested PCR to explore the association between HTLV-I infection and MF by screening genomic DNA from 114 skin biopsies for the presence of HTLV-I provirus. We also utilized a ViroChip and high-throughput sequencing (HTS), as a case study, to attempt to detect novel virus-specific oligonucleotides that may be associated with CTCL. Our data showed no evidence for HTLV-I proviral integration in the 114 MF samples that were screened using nested-PCR. The ViroChip and HTS results also did not reveal any signature sequence for known or unknown infectious agent in the CTCL case study. Collectively, this data argue against the involvement of HTLV-I provirus in the pathogenesis of MF.
APA, Harvard, Vancouver, ISO, and other styles
8

Ribeiro, Ana Isabel Freitas. "Biofilmes, microbiomas e infeções da pele." Master's thesis, 2019. http://hdl.handle.net/10284/8698.

Full text
Abstract:
A presente monografia tem como objetivo compreender os conceitos de biofilme e microbioma, e abordar algumas infeções da pele que poderão resultar do desequilíbrio do microbioma. Diferentes zonas da pele apresentam diferentes ecossistemas, sendo assim, habitadas por diferentes microrganismos. O microbioma representa a comunidade de microrganismos que naturalmente habitam no corpo humano, constituindo assim parte da identidade humana. Trata-se de um ecossistema complexo que reúne bactérias, fungos e vírus que vivem em comensalismo com o hospedeiro em diversos orgãos, incluindo na pele. A pele é conhecida como o maior orgão do corpo humano e assume grandes responsabilidades, nomeadamente a sua função termorreguladora e protetora. A pele está constantemente exposta a agentes agressores externos e é também aqui que se manifestam muitas respostas do sistema imunológico. Os biofilmes e microbiomas são, neste momento, tópicos relevantes de estudo. Os biofilmes podem saudáveis ou patogénicos. Os microbiomas contêm células no estado planctónico, no estado séssil e biofilmes. O desequilíbrio do microbioma pode ser manifestado pela presença de biofilmes patogénicos. É intuito deste trabalho fazer uma revisão da literatura desde 1978 a 2019, privilegiando os conteúdos mais recentes, que permita entender a dinâmica de biofilmes e microbiomas e constatar a influência do desequilíbrio destes nas infeções da pele.
This monograph aims to understand the concepts of biofilm and microbiome and address some skin infections that may result from the imbalance of the microbiome. Different areas of the skin have different ecosystems, thus being inhabited by different microorganisms. The microbiome represents the community of microorganisms that naturally inhabit the human body, thus forming part of the human identity. It is a complex ecosystem that brings together bacteria, fungi and viruses that live in commensalism with the host in various organs, including the skin. The skin is known as the largest organ of the human body and takes on great responsibilities, namely its thermoregulatory and protective function. The skin is constantly exposed to external aggressors and this is also where many immune system responses are manifested. Biofilms and microbiomes are currently relevant topics of study. Biofilms can be healthy or pathogenic. The microbiomes contain cells in planktonic state, sessile state and biofilms. The microbiome imbalance can be manifested by the presence of pathogenic biofilms. The aim of this paper is to review the literature from 1978 to 2019, focusing on the most recent contents, allowing to understand the dynamics of biofilms and microbiomes and to verify the influence of their imbalance on skin infections.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Seborrheic Dermatitis"

1

Nigel, Blatchford, Shuster Sam, and Royal Society of Medicine Services (Great Britain), eds. Seborrhoeic dermatitis and dandruff - a fungal disease. London: Royal Society of Medicine Services, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Parker, James N., and Philip M. Parker. Seborrheic dermatitis: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Omodo-Eluk, Albinus Joel. Studies on Malassezia Pachydermatis from the skin of dogs with allergic dermatitis and from dogs with seborrhoeic dermatitis. Dublin: University College Dublin, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Publications, ICON Health. Seborrheic Dermatitis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Treadwell, Patricia, ed. AM:STARs: Adolescent Dermatology, Vol. 22, No. 1. American Academy of Pediatrics, 2005. http://dx.doi.org/10.1542/9781581106398.

Full text
Abstract:
Published by the American Academy of Pediatrics, Adolescent Medicine: State of the Art Reviews helps you stay up-to-date in key areas of current clinical practice adolescent-specific topics in dermatology including: Dermatoses in Adolescents of Color, Alopecia in Adolescents, Cutaneous Manifestations of Connective Tissue Disease, Cutaneous Manlignancy in Adolescents, Acne Therapy in Primary Care: Comprehensive Review of Current Evidence-Based Interventions and Treatments, Body Art in Adolescents: Paint, Piercings, and Perils, Dermatologic Findings in the Evaluation of Adolescents with Suspected Eating Disorders, Cutaneous Infestations and Infections, Skin Findings Associated with Obesity, Papulosquamous Disorders: Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, and Nickel Contact Dermatitis.
APA, Harvard, Vancouver, ISO, and other styles
6

John, Arneson. Clobetasol Propionate: The Ultimate User Guide Used to Treat Skin Conditions Such As Psoriasis, Seborrheic Dermatitis, Eczema and Other Skin Conditions. Lulu Press, Inc., 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Esdaile, Ben. Eczema. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0250.

Full text
Abstract:
Eczema is a descriptive term for a set of symptoms and signs which usually involve itchy inflammation of the skin, and is subcategorized into many different forms. Atopic eczema (atopic dermatitis) is the most common chronic inflammatory disease amongst children. Other types of eczema include seborrhoeic eczema, discoid eczema, asteatotic eczema, contact allergic eczema, contact irritant eczema, pompholyx eczema, venous eczema, juvenile plantar dermatosis, and lichen simplex. This chapter covers atopic eczema, which is referred to as ‘atopic’ due to its association with other atopic disorders such as asthma and allergic rhinitis.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Seborrheic Dermatitis"

1

Theisler, Charles. "Seborrhea/Seborrheic Dermatitis/Dandruff." In Adjuvant Medical Care, 313–15. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

McGinley, Thomas, Kristine Cornejo, and Phelps Lambert. "Seborrheic Dermatitis." In Common Dermatologic Conditions in Primary Care, 87–97. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18065-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Curkova, Andrea Kovacikova, and Maria Simaljakova. "Seborrheic Dermatitis." In European Handbook of Dermatological Treatments, 867–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_87.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jackson-Richards, Diane. "Seborrheic Dermatitis." In Dermatology Atlas for Skin of Color, 109–13. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54446-0_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Treadwell, Patricia. "Seborrheic Dermatitis." In Atlas of Adolescent Dermatology, 57–59. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-58634-8_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

de Avelar Breunig, Juliano, and Marco Otavio Rocha Couto. "Seborrheic Dermatitis." In Dermatology in Public Health Environments, 429–47. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-33919-1_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rudnicka, Lidia, Justyna Sicinska, Adriana Rakowska, and Olga Warszawik-Hendzel. "Seborrheic Dermatitis." In Atlas of Trichoscopy, 371–78. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4486-1_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Norman, Robert A., and Edward M. Young. "Seborrheic Dermatitis." In Atlas of Geriatric Dermatology, 113–17. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4579-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Castillo, David E., Ilana Gunczler, Katlein França, and Jonette Keri. "Seborrheic Dermatitis." In Advances in Integrative Dermatology, 71–88. Chichester, UK: John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781119476009.ch6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Picardo, Mauro, and Norma Cameli. "Seborrheic Dermatitis." In Evidence-Based Dermatology, 169–74. Oxford, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118357606.ch25.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Seborrheic Dermatitis"

1

Dimitrova, Jenya. "Therapeutic efficacy of local choleclaciferol in facial seborrheic dermatitis." In The 5th Virtual International Conference on Advanced Research in Scientific Areas. Publishing Society, 2016. http://dx.doi.org/10.18638/arsa.2016.5.1.826.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kammerer, Susanne. "Roflumilast foam led to high response rates in seborrheic dermatitis." In EADV Congress 2022, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b3195d65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kim, Manjae, Sewoong Kim, Minjoo Hwang, Jihun Kim, Minkyu Je, Jae Eun Jang, Dong Hun Lee, and Jae Youn Hwang. "Multispectral imaging based on a Smartphone with an external C-MOS camera for detection of seborrheic dermatitis on the scalp." In SPIE BiOS, edited by Daniel L. Farkas, Dan V. Nicolau, and Robert C. Leif. SPIE, 2017. http://dx.doi.org/10.1117/12.2251707.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sahidah, Khaula Latifah Ramadhani, and Triana Agustin. "Correlation between Duration of Sun Exposure and Scalp Seborrheic Dermatitis Severity Score in the Dermatovenereology Clinic, Dr. Cipto Mangunkusumo General Hospital." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008152401320135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Seborrheic Dermatitis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography